Lars Rasmussen, BSc Engineering and MBA, was born on 31 March 1959 and is a Danish citizen. He was nominated for election to Lundbeck's Board of Directors at the 2013 Annual General Meeting. He is member of Lundbeck's Audit, Remuneration and Scientific Committee.
Lars Rasmussen has considerable management experience in global med-tech. Lars Rasmussen was appointed as CEO of Coloplast in 2008 and has been member of the company's Executive Management since 2001. In this period, he has been responsible for various functions in the group, including global sales, innovation and production. He has performed these duties from both Denmark and the USA.
Lars Rasmussen's special qualifications for serving on Lundbeck's Board of Directors include his top management experience and knowledge of efficiency improvements and internationalization.
Lars Rasmussen is member of the Board of Directors of Axcel.
Lene Skole, BCom Finance, was born on 28 April 1959 and is a Danish citizen. She was elected to Lundbeck’s Board of Directors at the 2015 Annual General Meeting. She is a member of Lundbeck's Remuneration and Scientific Committees.
Lene Skole is CEO at the Lundbeck Foundation. Prior to joining the Lundbeck Foundation in 2014, Lene Skole was CFO at Coloplast where she was a member of the company’s executive management since joining in 2005. Lene Skole’s responsibilities included finance, IT, HR, communication, strategy and M&A. Before 2005, Lene Skole held various positions in the AP Moller-Maersk group most recently as CFO of Maersk Company Ltd., London from 2000-2005.
Lene Skole’s special qualifications for serving on Lundbeck’s Board of Directors include extensive knowledge and expertise within financing, strategy, business development and M&A as well as management experience from international companies including med-tech.
Lene Skole is member of the Board of Directors of ALK-Abelló A/S and Tryg A/S.
Jesper Ovesen, MSc in finance and state authorized public accountant, was born on 20 March 1957 and is a Danish citizen. He was elected to Lundbeck’s Board of Directors at the 2015 Annual General Meeting. He chairs Lundbeck's Audit Committee.
Jesper Ovesen most recently held the position of Executive Chairman of Nokia Siemens Networks BV. Prior to this, he served as CFO in TDC A/S, Lego A/S and Danske Bank A/S and as Finance Director at Novo Nordisk A/S.
Jesper Ovesen’s special qualifications for serving on Lundbeck`s Board of Directors include his international management experience and his expertise in finance, accounting and international capital markets.
Jesper Ovesen is Vice Chairman of the Board of Directors of Scandinaviska Enskilda Banken AB and member of the Board of Directors of Sunrise Communications AG.
Lars Holmqvist, MSc in business administration, was born on 4 September 1959 and is a Swedish citizen. He elected to Lundbeck’s Board of Directors at the 2015 Annual General Meeting. He is a member of Lundbeck's Audit Committee.
Lars Holmqvist is Senior Advisor within healthcare at Bain Capital. He previously served as Vice President responsible for sales and marketing at Pharmacia. In addition, he has held management positions in several pharma and med-tech companies including Boston Scientific Corporation, Medtronic, Applied Biosystems Group, DAKO and Agilent Technologies.
Lars Holmqvist’s special qualifications for serving on Lundbeck`s Board of Directors include his international management experience, his expertise in finance and his sales and marketing experience from the global pharmaceutical, med-tech and life-science industry.
Lars Holmqvist is Chairman of the Board of Directors of Skutviken AB, and is nominated for election to the Board of Directors of the Lundbeck Foundation at the Annual Meeting of the Foundation in 2015.
Terrie Curran, BSc Applied Sciences and Graduate Diploma of Marketing, was born on 3 March 1969 and is an Australian citizen. She was nominated for election to Lundbeck’s Board of Directors at the 2014 Annual General Meeting. She is member of Lundbeck's Remuneration Committee.
Terrie Curran has comprehensive experience from the pharmaceutical industry from her executive roles with, inter alia, Merck and Celgene with responsibilities in sales, marketing and market access as well as licensing, alliance management, pipeline and portfolio management. She has held global commercial and marketing leadership roles and has since 2013 been appointed Corporate Vice President USA with Celgene Pharmaceuticals.
Terrie Curran’s special qualifications for serving on Lundbeck’s Board of Directors include strong global commercial experience and knowledge, including the US market. Her knowledge serves her as a discussion partner for the Board and Executive Management when it comes to commercialization and market access considerations.
Mona Elisabeth Elster has been employed with Lundbeck since 1994. She works in Discovery Chemistry & DMPK and was appointed Senior Lab Technician in 2009.
Mona Elisabeth Elster finished her Lab Technician education in 1984 and received a Marketing Diploma in 1989. She has previously worked with the Carlsberg Research Center, the Royal Veterinary and Agricultural University in Denmark, the Faculty of Pharmaceutical Sciences under the University of Copenhagen, and Danisco.
Since 1995, Mona Elisabeth Elster has been a member of the board of Lundbeck's salaried employees' association, where she was appointed chairman in 2002.
Jørn Mayntzhusen has been with Lundbeck since 2002 currently being Senior Manager for Supply Optimisation and Launches of new products. Previously Jørn Mayntzhusen has been responsible for Production Planning and Costing, as well as head of Customer Supply.
Originally educated as a banker in 1988 he has obtained a BSc in Logistics (HD(L)) at Copenhagen Business School in 1995 and a Master of Business Administration (MBA) from Edinburgh Business School in 2002.
Jørn Mayntzhusen started working with Handelsbanken 1986-1990 followed by 2 years at Thule Air Base with Greenland Contractors 1990-1992. In 1992 he started studying for his BSc and was employed as Logistic Assistant with Braun Nordic 1993-1997. For the next 2 years Jørn Mayntzhusen worked as Business Management Advisor with Mellemfolkeligt Samvirke in Zimbabwe. Prior to working for Lundbeck Jørn was Nordic Logistic Manager with Moulinex Krups 1999-2002.
Henrik Sindal Jensen, Ph.D. (Neuroscience) has been employed with Lundbeck since 2004. Currently, Henrik holds a position as Principal Scientist in Research acting as project manager and scientist involved in a number of Lundbeck’s preclinical research projects. In Research, Henrik has held a number of different positions including line management.
Henrik holds degrees in Molecular Biology (M.Sc.) and Chemistry (B.Sc) from the University of Aarhus and earned his industrial Ph.D. degree in collaboration between the Graduate School of Neuroscience at the University of Copenhagen and NeuroSearch. Prior to joining Lundbeck, Henrik held positions as Assistant Professor at the Department of Medical Physiology, University of Copenhagen and as Research Assistant at the Department of Molecular and Structural Biology, University of Aarhus.